TCTR20140610001已完成未知
Plasmin Enzyme-assisted Vitrectomy for Pediatric Patients with Vitreoretinal Diseases in Taiwan
Chang Gung Medical Research Project (CMRPG381661)0 个研究点目标入组 11 人开始时间: 2014年6月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 11
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 Months 至 16 Years（—）
- 性别
- All
入选标准
- •Patients aged 16 years or younger with vitreoretinopathy associated with abnormal vitreoretinal adhesion were enrolled for the use of plasmin as an adjuvant to vitreoretinal surgery
排除标准
- •Patients with active human immunodeficiency virus hepatitis B virus or hepatitis C were excluded from this trial Eyes with PVD at presentation sign of active infection history of uveitis or glaucoma uncontrolled by ocular hypotensive agents were excluded
研究者
相似试验
招募中
不适用
vitreous surgery with intravitreal tissue plasminogen activator(t-PA)globe ruptureJPRN-UMIN000015282Okayama University Hospital30
进行中（未招募）
1 期
Vitrectomy and subretinal TPA for submacular haemorrhage secondary to wet AMD (TIGER).Exudative age-related macular degenerationMedDRA version: 20.0Level: LLTClassification code: 10075718Term: Exudative age-related macular degeneration Class: 10015919CTIS2023-504751-28-00King's College London90
进行中（未招募）
1 期
A study of surgery to clear bleeding due to age-related macular degeneration.EUCTR2020-004917-10-DEKing's College London210
进行中（未招募）
不适用
Eye gel surgery for correction of the retinal hole and retinal membrane with or without cataract removalRBR-3wmd9sHospital das Clínicas de Ribeirão Preto
尚未招募
不适用
Treatment of plasminogen activator in ophthalmologySubmacular hemorrhage, Retinal vein occlusion, Fibrin formation due to postoperative inflammationJPRN-UMIN000029838Department of Ophthalmology, Kanazawa University10